The TCA cycle intermediates fumarate and succinate are potent JMJD inhibitors (Figure 1) and many cancers harbour mutations in genes encoding fumarate hydratase (FH) and/or the SDH complex, resulting in increased levels of both metabolites, leading to hypermethylation of histones [89]. Here, FH is linked to cancer.